List of YS Life Science APIs

Country: South Korea

Supplier Description: YS Life Science positions research as the cornerstone of its management philosophy. Guided by a strong commitment to the health and welfare of humanity, the company focuses on the development of innovative and high-quality medicines. Based on this philosophy, YS Life Science manufactures prostaglandins, bioactive materials, and high value-added active pharmaceutical ingredients (APIs). The company operates GMP-certified manufacturing facilities that have been approved by major global regulatory authorities, including the Korea Ministry of Food and Drug Safety (MFDS), the U.S. Food and Drug Administration (US FDA), the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan, and the European Medicines Agency (EMA). Prostaglandin-based drug substances are known for their highly complex and unstable structures, limiting global production to only a small number of technologically advanced manufacturers. YS Life Science is recognized as the only company in Korea capable of producing prostaglandin-based drug substances, demonstrating its exceptional technical expertise. Building on more than 25 years of accumulated technology and know-how, YS Life Science has secured multiple patents related to prostaglandin and high-potency API (HPAPI) synthesis. Products developed under these patented technologies are exported to over 40 countries worldwide, including the United States, Europe, and Japan. The company has also played a key role in the localization of drug substances that were previously entirely dependent on imports by domestic pharmaceutical companies. The ultra-high-purity prostaglandins produced using YS Life Science’s proprietary technologies are widely utilized in treatments for diseases such as glaucoma, gastric ulcers, and pulmonary hypertension, among others. The company’s technological excellence has been recognized through numerous awards, including the Korea Technology Award (2011) and the $10 Million Export Tower Award (2012), $20 Million Export Tower Award (2018), and $30 Million Export Tower Award (2021). Currently, YS Life Science manufactures approximately 20 types of prostaglandins and other high value-added drug substances. As an export-oriented API manufacturer and a leader in the Korean pharmaceutical market, the company continues to demonstrate strong and sustainable growth. Looking ahead, YS Life Science aims to lead the future biomedicine market through the development of novel drug products. In addition to API manufacturing, YS Life Science is actively expanding into the development and commercialization of finished dosage forms (FDFs), leveraging its differentiated technologies and expertise. The company is also broadening its business scope to include innovative drug development for the long-term well-being of humanity. Guided by its credo of “Top Quality, Best Service,” YS Life Science remains committed to earning lasting trust as a global pharmaceutical company. - Show More